BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17297725)

  • 21. National Institutes of Health. NCI gears up for cancer genome project.
    Kaiser J
    Science; 2005 Feb; 307(5713):1182. PubMed ID: 15731412
    [No Abstract]   [Full Text] [Related]  

  • 22. The genomic landscapes of human breast and colorectal cancers.
    Wood LD; Parsons DW; Jones S; Lin J; Sjöblom T; Leary RJ; Shen D; Boca SM; Barber T; Ptak J; Silliman N; Szabo S; Dezso Z; Ustyanksky V; Nikolskaya T; Nikolsky Y; Karchin R; Wilson PA; Kaminker JS; Zhang Z; Croshaw R; Willis J; Dawson D; Shipitsin M; Willson JK; Sukumar S; Polyak K; Park BH; Pethiyagoda CL; Pant PV; Ballinger DG; Sparks AB; Hartigan J; Smith DR; Suh E; Papadopoulos N; Buckhaults P; Markowitz SD; Parmigiani G; Kinzler KW; Velculescu VE; Vogelstein B
    Science; 2007 Nov; 318(5853):1108-13. PubMed ID: 17932254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Going on a cancer gene hunt.
    Bonetta L
    Cell; 2005 Dec; 123(5):735-7. PubMed ID: 16325563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
    Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
    Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer: drivers and passengers.
    Haber DA; Settleman J
    Nature; 2007 Mar; 446(7132):145-6. PubMed ID: 17344839
    [No Abstract]   [Full Text] [Related]  

  • 26. Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes.
    Bleeker FE; Lamba S; Rodolfo M; Scarpa A; Leenstra S; Vandertop WP; Bardelli A
    Hum Mutat; 2009 Feb; 30(2):E451-9. PubMed ID: 19058223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies.
    Collins FS; Barker AD
    Sci Am; 2007 Mar; 296(3):50-7. PubMed ID: 17348159
    [No Abstract]   [Full Text] [Related]  

  • 28. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
    Ching-Shian Leong V; Jabal MF; Leong PP; Abdullah MA; Gul YA; Seow HF
    Cancer Genet Cytogenet; 2008 Dec; 187(2):74-9. PubMed ID: 19027487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomics. Billion-dollar cancer mapping project steps forward.
    Kaiser J
    Science; 2008 Jul; 321(5885):26-7. PubMed ID: 18599748
    [No Abstract]   [Full Text] [Related]  

  • 30. Applications of genomic tools to colorectal cancer therapeutics.
    Auman JT; McLeod HL
    Curr Opin Mol Ther; 2008 Dec; 10(6):548-54. PubMed ID: 19051132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exome sequencing takes centre stage in cancer profiling.
    Maher B
    Nature; 2009 May; 459(7244):146-7. PubMed ID: 19444175
    [No Abstract]   [Full Text] [Related]  

  • 32. High rate of mutation in mitochondrial DNA displacement loop region in human colorectal cancer.
    Akouchekian M; Houshmand M; Hemati S; Ansaripour M; Shafa M
    Dis Colon Rectum; 2009 Mar; 52(3):526-30. PubMed ID: 19333057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic mutation of pro-cell death Bif-1 gene is rare in common human cancers.
    Kim MS; Yoo NJ; Lee SH
    APMIS; 2008 Oct; 116(10):939-40. PubMed ID: 19132989
    [No Abstract]   [Full Text] [Related]  

  • 34. Genomic profiling of colorectal cancer.
    Coyle VM; Johnston PG
    Eur J Cancer; 2009 Sep; 45 Suppl 1():371-4. PubMed ID: 19775635
    [No Abstract]   [Full Text] [Related]  

  • 35. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New breast cancer genes-discovery at the intersection of complex data sets.
    Nevins JR
    Cancer Cell; 2007 Dec; 12(6):497-9. PubMed ID: 18068627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer.
    Decock J; Paridaens R; Ye S
    Clin Genet; 2008 Mar; 73(3):197-211. PubMed ID: 18177467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.
    Deblois G; Hall JA; Perry MC; Laganière J; Ghahremani M; Park M; Hallett M; Giguère V
    Cancer Res; 2009 Aug; 69(15):6149-57. PubMed ID: 19622763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic susceptibility for breast cancer: how many more genes to be found?
    Oldenburg RA; Meijers-Heijboer H; Cornelisse CJ; Devilee P
    Crit Rev Oncol Hematol; 2007 Aug; 63(2):125-49. PubMed ID: 17498966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide, high-resolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays.
    Jacobs S; Thompson ER; Nannya Y; Yamamoto G; Pillai R; Ogawa S; Bailey DK; Campbell IG
    Cancer Res; 2007 Mar; 67(6):2544-51. PubMed ID: 17363572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.